DR. VINCENT C. GIAMPAPA, M.D.
Medical Practice at Valley Rd, Montclair, NJ

5443508, Aug 22, 1995

Nov 12, 1993

8/151377

Vincent C. Giampapa - Montclair NJ

A61F 202, A61K 922

623 11

An implantable multiple-agent biologic delivery system includes a pod proportioned for subcutaneous implantation beneath the dermis of the skin, the pod including a porous surface and having at least one internal chamber which is in fluid communication with the porous surface. The system includes a dome proportioned for selectable detachable securement to the chamber of the pod. The dome includes interior chambers, each in fluid communication with the interior of the pod. Bio-acting agents, such as hormones, enzymes, biologic response modifiers, free radical scavengers, and other genetically altered cell cultures may be provided, within the chambers of the dome, prior to implantation. Such agents within the dome will, through the use of time release micropumps, enter the interior chambers of the pod for transmission, through the porous surfaces into a growth factor stimulated capillary matrix and then to the bloodstream of the user. The pod may be removed, refilled, and resecured to the dome upon exhaustion of its contents or upon medical requirement for changes in medication, or may be percutaneously refilled in situ through injection into the dome.

5494677, Feb 27, 1996

Jun 28, 1993

8/082419

Vincent C. Giampapa - Montclair NJ

A61F 202, A61K 924, A61K 4730, A61K 4742

424426

A system for tissue-specific delivery of therapeutic agents includes an implantable element. biodegradable in situ within human tissue; a vasoinductive agent integrated into a surface of the element; and having the therapeutic agents incorporated into the implantable element. Upon implantation of the implantable element into tissue, the vasoinductive agent stimulates capillary growth, facilitating delivery of the therapeutic agents to the selected tissue.

2005019, Sep 8, 2005

Jan 28, 2005

11/046108

Vincent Giampapa - Montclair NJ, US

A61K031/7076, A61K031/455, A61K031/405, A61K035/78, A61K031/015, A61K033/32

424641000, 424725000, 514355000, 514047000, 514419000, 514763000

A treatment system for administering to a human or other animals and the method of use for improving resistance to DNA damage, enhancing DNA repair capacity and stimulating immune function are provided. The treatment system includes a carotenoid material; a nicotinamide material, a zinc source material, a water soluble extract material of an Uncaria species and a deuterium-reduced aqueous fluid containing 0.1 to 110 ppm deuterium.

2010029, Nov 18, 2010

May 18, 2010

12/781983

Vincent C. Giampapa - Montclair NJ, US

A61K 9/127, A61K 36/00

424450, 424773

A topical composition for anti-aging treatment of the skin includes water soluble extract of species, extract, lipoic acid, dimethylethanolamine, tetrahexyldecyl ascorbate, dimethyl sulfoxide, (Licorice) root extract, methylsulfonylmethane, phytosterols, D-ribose, tocotrienol, tocopherol, glucosamine hydrochloride, extract; extract, and a dermatologically acceptable liposomal delivery medium. Further disclosed is a method using the topical composition for anti-aging skin treatment utilizing DNA repair in both the nucleus and the mitochondria. The topical composition can be applied on the skin of a person daily, and can also be applied in a dermal infusion treatment, with or without micro-dermal abrasion or skin suction. Topical application of the composition achieves effective reduction of pigmentation spots and degree of winkles, and improvement of skin color tone.

2012014, Jun 14, 2012

Feb 23, 2012

13/403473

Vincent C. GIAMPAPA - Montclair NJ, US

A61K 8/73, A61Q 19/08, A61K 8/02

424401, 514 65

A treatment method for restoring of age related tissue loss in the face or selected areas of the body is disclosed which includes injecting an injectable composition containing a growth factor and hyaluronic acid as a carrier into the dermis, the hypodermis, or both, in various areas of the face, or selected areas of the body of a person to stimulate collagen, elastin, or fat cell production, thereby restoring age related tissue loss in the face and selected areas of the body. Further disclosed is an injectable composition for restoring of age related tissue loss in the face and selected areas of the body, which contains a growth factor and hyaluronic acid as a carrier for providing time release of the growth factor into tissues. The growth factor can be insulin, insulin-like growth factor, thyroid hormone, fibroblast growth factor, estrogen, retinoic acid, or their combinations.

5580569, Dec 3, 1996

Nov 4, 1993

8/145569

Vincent C. Giampapa - Montclair NJ

A61F 202, A61K 924, A61M 3100, A61B 1736

424426

An article for tissue-specific delivery of therapeutic agents constitutes a substrate of a material that is biodegradable in situ in human tissue, which substrate is configured into a projectile and proportioned for insertion into a channel of an endoscope, the substrate having incorporated thereinto selectable therapeutic agents to be delivered, the projectile including, upon an exterior surface, a capacity for tissue affixation to the tissue of interest.

5421831, Jun 6, 1995

Jul 14, 1992

7/913011

Vincent C. Giampapa - Montclair NJ

A61F 228

623 16

A facial implant for augmentation of the sub-malar region of the face includes a three dimensional body formed of a flexible tissue-compatible material having a convex front surface and a concave rear surface, such surfaces being substantially symmetrical about a plane of symmetry existing about midway between proximal and distal tips of the body, at which tips the convex and concave surfaces intersect. The body is also characterized by a thin proximal head portion consisting of upper and lower protrusions existing proximally with reducing thickness, a wider central portion, and a tail portion extending distally with reducing height and thickness to the distal tip of the body of the implant.

2012018, Jul 26, 2012

May 4, 2010

13/318524

Vincent Giampapa - Montclair NJ, US
Robin L. Smith - New York NY, US

NEOSTEM, INC. - New York NY

A61K 35/12, A61K 35/14, A61P 17/00, A61K 35/28

424 937

This application relates to stem cell compositions and methods for restoring age-related tissue loss in the face and other selected areas of the body. In a first embodiment, a composition includes stem cells and hyaluronic acid as a carrier wherein the stem cells are peripheral blood stem cells, bone marrow-derived blood stem cells, or mesenchymal stem cells.

5195951, Mar 23, 1993

Mar 25, 1991

7/674394

Vincent C. Giampapa - Montclair NJ

A61F 228

623 16

The implant for the chin is defined by a solid crescent formed by the intersection of an interior radius of curvature with an exterior radius of curvature in which the interior radius is slightly smaller than the exterior radius, the resulting crescent having a total included angle of approximately forty-five degrees. An outer portion of the implant is provided with a softer, lower durometer material than is the rest of the implant to simulate the fat pad at the point of the chin.